
Crystagen
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
Crystagen is a short synthetic peptide bioregulator (Glutamate-Aspartate-Proline-Arginine) from the Khavinson family, associated with immune regulation.
| Test | Result | Status |
|---|---|---|
| Purity | 99.3% | Passed ✓ |
Research Information
Crystagen is investigated for peptide-bioregulator effects on immune-cell gene expression and function in laboratory models of immune homeostasis, alongside other tissue-specific short peptides. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
Crystagen Research & Studies
What is Crystagen?
Crystagen is a short synthetic tetrapeptide bioregulator with the defined amino acid sequence Glutamate-Aspartate-Proline-Arginine. It belongs to the Khavinson family of cytomedin-type peptides and is examined in laboratory contexts for associations with immune regulation. Research focuses on its properties as a tissue-oriented short peptide in controlled experimental systems. The compound is supplied strictly for in-vitro and laboratory research use only.
Mechanism of Action
Laboratory investigations of Crystagen center on its potential interactions with gene expression machinery in immune-related cell models. Short peptide bioregulators of this class are studied for membrane penetration and subsequent influence on transcription of genes linked to cellular immune function. Experimental work explores effects on protein synthesis patterns and differentiation markers within cultured immune cells. These studies map molecular pathways under strictly controlled in-vitro conditions.
Primary Areas of Research
Primary research areas for Crystagen involve peptide-bioregulator effects on immune-cell gene expression and functional responses. Scientists examine the compound in laboratory models of immune homeostasis using isolated cell systems and comparative peptide panels. Investigations often place Crystagen alongside other tissue-specific short peptides to characterize selective regulatory profiles. Emphasis remains on elucidating cellular signaling and transcriptional outcomes in experimental settings.
Key Research Findings
Published laboratory work on Khavinson-type short peptides, including Crystagen, documents measurable shifts in gene expression profiles within immune cell cultures. Model-system findings describe modulation of transcriptional activity related to immune-cell functional states under defined experimental conditions. Structural features of the tetrapeptide are analyzed for possible nuclear or chromatin interactions. All reported observations derive from in-vitro assays focused on molecular and cellular mechanisms.
Research Handling & Considerations
Crystagen is designated exclusively for research use and requires handling according to standard laboratory peptide protocols. Investigators typically store the lyophilized material at low temperatures to preserve chemical integrity prior to experimental use. Reconstitution for cell-culture or biochemical assays demands sterile technique and suitable solvents. Accurate recording of purity, concentration, and batch data supports reproducibility across in-vitro studies of immune-related pathways.
Frequently Asked Questions
Crystagen is the synthetic tetrapeptide Glutamate-Aspartate-Proline-Arginine, examined as a short bioregulator in laboratory research.
Explore Other High-Purity Peptides

Thymalin

Thymosin Alpha-1

Bronchogen
